IRIS
MOAVERO, ROMINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.352
AS - Asia 3.441
EU - Europa 2.277
SA - Sud America 474
Continente sconosciuto - Info sul continente non disponibili 367
AF - Africa 58
OC - Oceania 26
Totale 26.995
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.236
SG - Singapore 1.773
IT - Italia 609
CN - Cina 442
BR - Brasile 380
RU - Federazione Russa 329
HK - Hong Kong 306
VN - Vietnam 281
IE - Irlanda 241
DE - Germania 238
UA - Ucraina 224
FR - Francia 159
BD - Bangladesh 152
GB - Regno Unito 144
KR - Corea 133
JP - Giappone 100
FI - Finlandia 85
NL - Olanda 75
IN - India 56
SE - Svezia 53
CA - Canada 49
TW - Taiwan 47
PL - Polonia 46
AR - Argentina 41
MX - Messico 30
AU - Australia 26
AT - Austria 23
ID - Indonesia 22
IQ - Iraq 21
TR - Turchia 20
ZA - Sudafrica 16
EC - Ecuador 13
ES - Italia 13
CO - Colombia 12
MA - Marocco 11
SA - Arabia Saudita 10
UZ - Uzbekistan 10
MY - Malesia 9
PH - Filippine 9
CZ - Repubblica Ceca 8
TH - Thailandia 8
VE - Venezuela 8
CR - Costa Rica 7
DZ - Algeria 7
EG - Egitto 7
JM - Giamaica 7
PK - Pakistan 7
AE - Emirati Arabi Uniti 6
KE - Kenya 6
PE - Perù 6
TT - Trinidad e Tobago 6
BG - Bulgaria 5
EU - Europa 5
PY - Paraguay 5
RO - Romania 5
JO - Giordania 4
KZ - Kazakistan 4
UY - Uruguay 4
BO - Bolivia 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
LB - Libano 3
NI - Nicaragua 3
SV - El Salvador 3
BE - Belgio 2
BH - Bahrain 2
CL - Cile 2
ET - Etiopia 2
FO - Isole Faroe 2
GR - Grecia 2
IL - Israele 2
IR - Iran 2
LK - Sri Lanka 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
SM - San Marino 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
HT - Haiti 1
KG - Kirghizistan 1
KM - Comore 1
KN - Saint Kitts e Nevis 1
LC - Santa Lucia 1
LT - Lituania 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
MR - Mauritania 1
NG - Nigeria 1
Totale 26.627
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.442
Wilmington 4.709
Houston 3.815
Singapore 891
Fairfield 743
San Jose 497
Ashburn 462
Ann Arbor 413
Chandler 316
Seattle 308
Hong Kong 300
Cambridge 232
Dublin 230
Council Bluffs 198
Jacksonville 191
Medford 178
Santa Clara 158
Beijing 151
Rome 146
New York 133
Los Angeles 113
The Dalles 104
Dallas 98
Dearborn 97
Ho Chi Minh City 89
Lawrence 88
Tokyo 80
Buffalo 78
Hanoi 75
Chicago 70
Lauterbourg 65
Moscow 58
Taipei 42
Menlo Park 36
San Diego 36
Norwalk 35
Kraków 33
Milan 33
São Paulo 33
Munich 29
North Bergen 29
London 26
Nuremberg 25
Salt Lake City 25
Haiphong 20
Redondo Beach 20
Jakarta 18
Lappeenranta 18
Orem 18
Helsinki 17
Mülheim 16
Atlanta 15
Frankfurt am Main 15
Amsterdam 14
Brooklyn 14
Chennai 14
Del Norte 14
Miami 14
Phoenix 14
Redwood City 14
Rio de Janeiro 14
Elk Grove Village 13
Montreal 13
Boardman 12
Melbourne 12
Warsaw 12
Bologna 11
Mexico City 11
Naples 11
Seoul 11
Stockholm 11
Vienna 11
Denver 10
Lancaster 10
Shanghai 10
Villa Adelina 10
Curitiba 9
Da Nang 9
Johannesburg 9
Mumbai 9
San Francisco 9
Turin 9
Catania 8
Kuala Lumpur 8
Manchester 8
Modena 8
New Delhi 8
Paris 8
Redmond 8
Ribeirão Preto 8
Sterling 8
Sydney 8
Tashkent 8
University Center 8
Bethesda 7
Boston 7
Brno 7
Charlotte 7
Falls Church 7
Genoa 7
Totale 21.539
Salva come PNG Salva come JPEG
Nome #
Current role of perampanel in pediatric epilepsy 539
Neurological and neuropsychiatric aspects of tuberous sclerosis complex. 506
The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions 469
Cognitive development in females with PCDH19 gene-related epilepsy 467
mTOR Inhibitors in Tuberous Sclerosis Complex. 452
Peri-ictal water drinking: a rare automatic behaviour in temporal lobe epilepsy 450
Current role of melatonin in pediatric neurology: Clinical recommendations 446
Genotype/Phenotype Correlations in Tuberous Sclerosis Complex. 441
Rufinamide for the treatment of refractory epilepsy secondary to neuronal migration disorders. 436
Timing and clinical characteristics of topiramate-induced psychosis in a patient with epilepsy and tuberous sclerosis 432
Cognitive and behavioral effects of new antiepileptic drugs in pediatric epilepsy 431
Mammalian Target of Rapamycin Inhibitors and Life-Threatening Conditions in Tuberous Sclerosis Complex. 429
Reduction in retinal nerve fiber layer thickness in tuberous sclerosis complex. 426
The neurobiology of attention deficit/hyperactivity disorder. 423
Is mTOR inhibition a systemic treatment for tuberous sclerosis? 423
Long-term follow-up in children with benign convulsions associated with gastroenteritis 419
Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC 415
Syndromic autism: Causes and pathogenetic pathways 414
Clinical Reasoning: A girl presenting with stiffness episodes during sleep, café-au-lait spots, and flecked retina 413
Abnormal parieto-motor connectivity in Tuberous Sclerosis Complex 409
Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex 407
Metastatic Group 3 Medulloblastoma in a Patient With Tuberous Sclerosis Complex: Case Description and Molecular Characterization of the Tumor 402
The Challenge of Pharmacotherapy in Children and Adolescents with Epilepsy-ADHD Comorbidity 400
Current role of rufinamide in the treatment of childhood epilepsy: literature review and treatment guidelines 399
Headache and attention deficit and hyperactivity disorder in children: common condition with complex relation and disabling consequences 399
Risk and Protective Environmental Factors Associated with Autism Spectrum Disorder: Evidence-Based Principles and Recommendations 397
Pancreatic neuroendocrine tumor in a child with a tuberous sclerosis complex 2 (TSC2) mutation 392
Ketogenic diet in early myoclonic encephalopathy due to non ketotic hyperglycinemia 391
Autism spectrum disorders in tuberous sclerosis: pathogenetic pathways and implications for treatment. 390
Combined targeted treatment in early onset epilepsy associated with tuberous sclerosis 386
Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis. 384
Rufinamide efficacy and safety as adjunctive treatment in children with focal drug resistant epilepsy: The first Italian prospective study 384
White matter disruption is associated with persistent seizures in tuberous sclerosis complex 383
The neurobiological basis of ADHD. 382
Tubers, epileptogenic foci, and epileptogenic networks in tuberous sclerosis. 382
Everolimus Alleviates Obstructive Hydrocephalus due to Subependymal Giant Cell Astrocytomas 381
The management of subependymal giant cell tumors in tuberous sclerosis: a clinician's perspective 380
Epilepsy secondary to tuberous sclerosis: lessons learned and current challenges. 377
Attention deficit hyperactivity disorder in children with epilepsy. 372
MTOR inhibitors as a new therapeutic option for epilepsy 366
Paediatric use of melatonin (Author reply to D. J. Kennaway). 363
Early control of seizures improves long-term outcome in children with tuberous sclerosis complex 359
Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations. 359
Can we change the course of epilepsy in tuberous sclerosis complex? 348
Syndrome of Transient Headache and Neurologic Deficits With Cerebrospinal Fluid Lymphocitosis Should Be Considered in Children Presenting With Acute Confusional State 346
New perspectives in Autism spectrum disorder associated with tuberous sclerosis 338
Vagus nerve stimulation for refractory epilepsy in tuberous sclerosis. 309
Management of epilepsy associated with tuberous sclerosis complex: Updated clinical recommendations 303
Pharmacotherapy of idiopathic generalized epilepsies 300
Neuroimaging findings of Sturge-Weber Syndrome in a child with Tuberous Sclerosis 297
Safety and tolerability profile of new antiepileptic drug treatment in children with epilepsy 292
Recent advances in neurobiology of Tuberous Sclerosis Complex 276
A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND) 270
Autism spectrum disorder and 3p24.3p23 triplication: a case report 260
A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: A Delphi consensus report 199
Early Clinical Predictors of Autism Spectrum Disorder in Infants with Tuberous Sclerosis Complex: Results from the EPISTOP Study 193
mTOR dysregulation and tuberous sclerosis-related epilepsy 189
Everolimus for Retinal Astrocytic Hamartomas in Tuberous Sclerosis Complex 183
Cyclic vomiting syndrome and benign paroxysmal torticollis are associated with a high risk of developing primary headache: A longitudinal study 163
Restless legs syndrome and growing pains in childhood: understanding the link 158
Clinical Features of Pediatric Idiopathic Intracranial Hypertension and Applicability of New ICHD-3 Criteria 157
Prophylactic treatment of pediatric migraine: Is there anything new in the last decade? 150
Features of primary chronic headache in children and adolescents and validity of ICHD 3 criteria 150
Immediate and prolonged-release melatonin in children with neurodevelopmental disabilities. Author reply to Prof. Zisapel 146
Sleep-related painful erection: the first case in a child 138
Is autism driven by epilepsy in infants with Tuberous Sclerosis Complex? 136
Tolerability of palmitoylethanolamide in a pediatric population suffering from migraine: a pilot study 126
Case Report: Migralepsy: The Two-Faced Janus of Neurology 125
Sleep disturbances and behavioral symptoms in pediatric Sotos syndrome 124
Subacute Sclerosing Panencephalitis in Children: The Archetype of Non-Vaccination 118
Safety of SARS-CoV2 vaccination and COVID-19 short-term outcome in pediatric acquired demyelinating disorders of central nervous system: A single center experience 117
Primary Headaches and Sleep Disorders: Review of Literature about Comorbidity in Children and Adolescents 109
Diagnosis of pediatric anti-NMDAR encephalitis at the onset: A clinical challenge 109
Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial 109
Restless sleep disorder in a sample of children and adolescents with autism spectrum disorder: preliminary results from a case series 108
Clinical Variability of Pediatric MERS: Insights from a Retrospective Observational Study 107
Benign Intracranial Hypertension Due to Hypoparathyroidism: A Case Report 107
Autism and epilepsy in patients with Tuberous Sclerosis Complex 104
Anxiety, Depression, and Body Weight in Children and Adolescents With Migraine 104
Questionnaire-based assessment of sleep disorders in an adult population of Tuberous Sclerosis Complex 102
Pediatric Neuromyelitis Optica Spectrum Disorder: Case Series and Literature Review 102
Sleep Disorders in Pediatric Migraine: A Questionnaire-Based Study 96
A Case Report of Pediatric Patient with Tuberous Sclerosis and Radiologically Isolated Syndrome 96
Long-Term Effects of COVID-19 Pandemic on Migraine in Adolescents. A Retrospective Analysis of the Population Attending the Headache Center in Different Phases of the Pandemic 90
I stay at home with headache. A survey to investigate how the lockdown for COVID-19 impacted on headache in Italian children 89
Early epileptiform EEG activity in infants with tuberous sclerosis complex predicts epilepsy and neurodevelopmental outcomes 81
Screen exposure and sleep: How the COVID-19 pandemic influenced children and adolescents - A questionnaire-based study 79
Sleep disorders and neuropsychiatric disorders in a pediatric sample of tuberous sclerosis complex: a questionnaire-based study 79
High Intellectual Potential and High Functioning Autism: Clinical and Neurophysiological Features in a Pediatric Sample 76
Prenatal mTOR Inhibitors in Tuberous Sclerosis Complex: Current Insights and Future Directions 74
Genetic pathogenesis of the epileptogenic lesions in Tuberous Sclerosis Complex: Therapeutic targeting of the mTOR pathway 74
Case report: A pediatric case of Bickerstaff brainstem encephalitis after COVID-19 vaccination and Mycoplasma pneumoniae infection: Looking for the culprit 73
Event-Related Potentials in ADHD Associated With Tuberous Sclerosis Complex: A Possible Biomarker of Symptoms Severity? 73
Interictal Cognitive Performance in Children and Adolescents With Primary Headache: A Narrative Review 71
miRNAs and isomiRs: Serum-Based Biomarkers for the Development of Intellectual Disability and Autism Spectrum Disorder in Tuberous Sclerosis Complex 70
Migraine and Its Equivalents: What Do They Share? A Narrative Review on Common Pathophysiological Patterns 70
Sleep Disorders in a Sample of Patients with Pediatric-Onset Multiple Sclerosis: Focus on Restless Legs Syndrome 69
Medication Overuse Withdrawal in Children and Adolescents Does Not Always Improve Headache: A Cross-Sectional Study 68
Surgery for drug-resistant tuberous sclerosis complex-associated epilepsy: who, when, and what 66
How to Assess the Headache—Sleep Disorders Comorbidity in Children and Adolescents 65
Totale 26.106
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.776
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.776
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022696 0 53 28 9 18 62 25 21 159 54 52 215
2022/2023848 96 89 17 81 79 232 87 35 67 3 39 23
2023/2024407 42 9 21 3 28 97 8 3 2 12 96 86
2024/20252.821 57 662 353 153 80 178 140 101 140 452 254 251
2025/20264.516 298 193 482 270 496 141 566 558 492 330 350 340
2026/2027526 325 201 0 0 0 0 0 0 0 0 0 0
Totale 26.995